Emmaus Life Sciences, Inc. (EMMAW) .
本页证实的标准:
SharesGrow 综合评分： 19/100 其中 0/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2014 | $-0.05 | $135.1K | $-2.66M | -1968.9% |
| 2015 | $-0.07 | $100.1K | $-3.39M | -3382.6% |
| 2016 | $-0.12 | $85.1K | $-5.94M | -6981.2% |
| 2017 | $-0.14 | $128.5K | $-7.11M | -5535.4% |
| 2018 | $-0.21 | $1.32M | $-10.33M | -785.2% |
| 2019 | $-1.11 | $22.75M | $-54.84M | -241% |
| 2020 | $0.02 | $23.17M | $1.1M | 4.7% |
| 2021 | $-0.32 | $20.61M | $-15.95M | -77.4% |
| 2024 | $-0.10 | $16.65M | $-6.45M | -38.7% |
| 2025 | $-0.12 | $12.45M | $-7.49M | -60.2% |
